3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Terminated
1
Recruiting
1
Not yet recruiting
1
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Rectal Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Colorectal Neoplasms
1
Interventions
Specimen Handling
78
Cisplatin
66
Carboplatin
64
Drug Therapy
63
Magnetic Resonance Spectroscopy
62
Bevacizumab
62
Radiotherapy
57
Cyclophosphamide
56
Gemcitabine
54
pembrolizumab
52
Capecitabine
50
Oxaliplatin
49
toripalimab
45
Paclitaxel
41
tislelizumab
40
Standard of Care
39
Biopsy
37
fludarabine
36
Injections
36
Fluorouracil
34
venetoclax
33
Blood Specimen Collection
31
Immune Checkpoint Inhibitors
30
anlotinib
29
Docetaxel
28
Surgical Procedures, Operative
27
Leucovorin
27
Irinotecan
27
Dexamethasone
27
Nivolumab
26
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Water
×
1 year
×
Clear all
NCT07321847
2026-01-07
INJECTABL-3
Immunophotonics, Inc.
Phase 2/3
Not yet recruiting
717 enrolled